Finch Therapeutics Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	2	6	23	474	1,029	1,029
Market Cap Growth	-	-74.70%	-95.17%	-53.97%	0%	-
Enterprise Value	11	11	4	346	931	1,130
PE Ratio	-0.26	-0.08	-0.20	-8.48	-26.22	-50.43
PS Ratio	0.76	54.13	26.59	25.56	133.32	101.35
PB Ratio	0.11	0.25	0.24	2.34	-10.75	-17.29
P/FCF Ratio	-0.18	-0.18	-0.30	-5.70	-30.30	-56.16
P/OCF Ratio	-0.18	-0.18	-0.31	-7.06	-32.85	-59.42
EV/Sales Ratio	3.86	100.88	4.87	18.68	120.64	111.29
EV/EBITDA Ratio	-0.55	-0.33	-0.06	-5.77	-24.10	-55.07
EV/EBIT Ratio	-0.55	-0.32	-0.05	-5.56	-23.62	-53.81
EV/FCF Ratio	-0.57	-0.34	-0.05	-4.17	-27.42	-61.67
Debt / Equity Ratio	1.55	1.32	0.55	0.03	-0.02	-2.41
Debt / EBITDA Ratio	-1.27	-0.93	-0.70	-0.10	-0.05	-6.98
Debt / FCF Ratio	-1.32	-0.96	-0.68	-0.07	-0.05	-7.81
Quick Ratio	5.93	6.15	4.85	9.06	8.78	6.41
Current Ratio	6.05	6.33	4.84	9.03	9.24	6.64
Asset Turnover	0.04	0.00	0.01	0.08	0.05	0.10
Interest Coverage	-18.44	0	-3.26	0	0	0
Return on Equity (ROE)	-85.53%	-326.64%	-118.79%	-27.62%	41.00%	34.28%
Return on Assets (ROA)	-32.51%	-105.29%	-69.78%	-24.79%	-23.74%	-19.70%
Return on Capital (ROIC)	-48.37%	-64.14%	-78.08%	-28.81%	41.99%	-25.28%
Earnings Yield	-751.14%	-1290.55%	-496.68%	-11.79%	-3.81%	-1.98%
FCF Yield	-1036.64%	-543.90%	-336.51%	-17.55%	-3.30%	-1.78%
Buyback Yield / Dilution	-0.18%	-0.93%	-0.38%	1.57%	-	-
Total Shareholder Return	-0.18%	-0.93%	-0.38%	1.57%	-	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.